purpose analyzed results uveal melanoma treatment proton beam irradiation series patients NUMBER years patients methods patients treated proton beam radiation september NUMBER december NUMBER initial examination including visual acuity funduscopy b scan ultrasonography eye fundus photographs fluorescein angiography general examination included chest radiography b scan ultrasonography liver tumors received total dose NUMBER equivalents applied daily fractions orsay proton therapy center results total NUMBER patients treated median NUMBER months median age NUMBER years thirteen tumors anterior equator NUMBER overlapped equator NUMBER posterior equator initial retinal detachment present NUMBER cases optic disk invaded NUMBER cases median tumor diameter NUMBER mm median tumor thickness NUMBER mm mean initial acuity survival rate NUMBER NUMBER years NUMBER deaths resulted metastasis statistically significant risk factors death identified multivariate analysis tumor diameter greater NUMBER mm p00004 age NUMBER years p00001 metastasis rate NUMBER years NUMBER liver affected NUMBER patients risk factors metastasis anterior site tumor volume greater NUMBER cc presence retinal detachment diagnosis secondary enucleation rate NUMBER years NUMBER mainly attributable secondary neovascular glaucoma local recurrence rate NUMBER visual acuity rate NUMBER patients better NUMBER years visual loss mainly postradiation maculopathy neuropathy conclusion study confirms results literature proton beam radiation therapy allows good tumor control excellent eye retention rate good final visual acuity approximately half patients long term follow cobalt gray follow long term NUMBER NUMBER NUMBER NUMBER